ECEESPE2025 Poster Presentations Thyroid (141 abstracts)
1Ankara Bilkent City Hospital, Department of Endocrinology and Metabolism, Ankara, Türkiye; 2Ankara Yildirim Beyazit University Faculty of Medicine, Department of Nuclear Medicine, Ankara, Türkiye; 3Ankara Yildirim Beyazit University Faculty of Medicine, Department of Pathology, Ankara, Türkiye; 4Ankara Yildirim Beyazit University Faculty of Medicine, Department of Endocrinology and Metabolism, Ankara, Türkiye
JOINT1227
Background: Gallium-68 DOTA-TATE PET/CT is a widely utilized imaging modality for neuroendocrine tumors (NETs) due to its sensitivity for somatostatin receptors (SSTRs). However, incidental uptake in the thyroid is increasingly noted, raising questions about its clinical significance. This study analyzes ultrasonographic and clinicopathological features of patients with thyroid Ga-68 DOTA-TATE uptake.
Methods: This retrospective study included 39 patients who underwent Ga-68 DOTA-TATE PET/CT imaging from April 2019 to November 2023, exhibiting thyroid uptake categorized as focal, diffuse, or heterogeneous. Ultrasonographic evaluations, fine-needle aspiration biopsies (FNAB), and laboratory tests, including thyroid function and autoimmune markers, were reviewed. Statistical analyses assessed relationships between uptake patterns, SUVmax, and clinical parameters.
Results: Focal uptake was noted in 59% of patients, diffuse in 17.9%, and heterogeneous in 23.1%. Focal Ga-68 DOTA-TATE uptake in the thyroid gland remains a potential indicator of malignancy. Although no cases of carcinoma were confirmed in this cohort, the observed focal uptake emphasizes the importance of vigilant follow-up and thorough diagnostic evaluations such as ultrasonography and FNAB. FNAB was performed on 82% of patients with suspicious nodules; 33.3% yielded non-diagnostic Results Diffuse uptake correlated with benign conditions like Hashimotos thyroiditis. The mean SUVmax was 7.35 ± 3.08.
Ultrasonographic Findings: 87.2% of patients had nodular or multinodular goiter. Of these, 20.5% showed chronic thyroiditis. Mixed nodule structure predominated (68.6%), and 48.6% exhibited isoechoic patterns. FNAB results were benign in 46.7% and atypia of undetermined significance (AUS) in 17.8%, with one case identified as follicular neoplasm.
Discussion: Focal Ga-68 DOTA-TATE uptake in the thyroid may signify malignancy risk, underscoring the need for systematic evaluation. Diffuse uptake aligns more commonly with benign thyroid diseases, particularly autoimmune conditions. An inverse relationship between SUVmax and BMI hints at metabolic and inflammatory influences on SSTR expression. High non-diagnostic FNAB rates indicate challenges in conclusive diagnoses, warranting further studies.
Parameter | Value |
Focal uptake | 59% |
Diffuse uptake | 17.9% |
Heterogeneous uptake | 23.1% |
SUVmax | 7.35 ± 3.08 |
Non-diagnostic final FNAB results | 33.3% |
Nodular/multinodular goiter | 87.2% |
Chronic thyroiditis (isolated) | 10.3% |
Isoechoic nodule patterns | 48.6% |
Mixed nodule structures | 68.6% |
Conclusion: Focal Ga-68 DOTA-TATE uptake is a potential marker of malignancy, while diffuse uptake often suggests benign pathology. Comprehensive diagnostic approaches, including ultrasonography and FNAB, are critical for incidental thyroid findings on Ga-68 DOTA-TATE PET/CT imaging. Further research on SUVmax correlations with metabolic factors is needed to refine patient management strategies.